Gland Pharma to invest $21 million in US drugmaker, take 60% stake
Gland Pharma‘s board has approved a $21 million investment in its US subsidiary, Gland Pharma USA Inc., which will use the funds to acquire a 60% stake in newly incorporated Novelstar Pharma Inc., according to a regulatory filing on Thursday. The investment is aimed at expanding Gland Pharma’s business in the US. The transaction is…
